They often travel with bloating, pressure, reflux, or an overly full stomach
At Mayfair Weight Loss Clinic, clinician-led assessments help ensure treatment remains safe, effective, and well tolerated
By activating both GIP and GLP-1 receptors, it provides a more comprehensive approach to managing blood sugar levels and promoting weight loss
The exact timeline depends on the peptide used, dosage consistency, metabolism, and your specific treatment goals
Can a patient who developed a bowel obstruction while on a GLP1 receptor agonist (e.g., exenatide, liraglutide, semaglutide, dulaglutide) safely continue the GLP1 therapy?
Beyond weight reduction, these trials revealed significant improvements in metabolic markers and inflammatory biomarkers that correlate with long-term health outcomes